GranuFlo is used in Dialysis treatment. it has been recalled due to sudden heart attacks and deaths. Heart attack from dialysis medication lawyers are filing lawsuits for deaths from dialysis medications.
Definitions
and Kindney Disease Overview
Chronic kidney disease
(CKD): any condition that causes reduced kidney function over a period of time. CKD is present when a patient’s glomerular filtration rate remains below 60 milliliters per minute for more than 3 months or when a patient’s urine albumin-to-creatinine ratio is over 30 milligrams (mg) of albumin for each gram (g) of creatinine (30 mg/g).
End-stage renal disease (ESRD):
total and permanent kidney failure. When the kidneys fail, the body retains fl uid. Harmful wastes build up. A person with ESRD needs treatment to replace the work of the failed kidneys.
Acute kidney injury (AKI):
sudden, temporary, and sometimes fatal loss of kidney function
incidence:
the number of new cases of a disease in a given time period
prevalence:
the number of existing cases of a disease at a given point in time
Chronic Kidney Disease, Dialysis and GranuFlo. GranuFlo is a Threat to Seniors
-
The incidence of CKD is increasing most rapidly in people ages
65 and older.
-
The incidence of recognized CKD in people ages
65 and older
more than doubled between 2000 and 2008.
-
The incidence of recognized CKD among 20- to 64-year-olds is less than 0.5 percent.
CKD Prevalence
,
GranuFlo Threat in 60 and Over Population
The prevalence of CKD is growing most rapidly in people ages
60 and older.
Between the 1988–1994 National Health and Nutrition Examination Survey (NHANES) study and the 2003–2006 NHANES study, the prevalence of CKD in people ages
60 and older
jumped from 18.8 to 24.5 percent.
During that same period, the prevalence of CKD in people between the ages of 20 and 39 stayed consistently below 0.5 percent.
Dialysis Statistics By State
-
Alabama: 7,334
-
Alaska: 350
-
Arizona: 6,747
-
Arkansas:2,905
-
California: 45,047
-
Colorado: 3,360
-
Connecticut: 3,497
-
DC:1,809
-
Delaware: 1,170
-
Florida: 20,365
-
Georgia: 14,086
-
Hawaii: 2,449
-
Idaho: 916
-
I
llinois: 15,268
-
Indiana: 6,539
-
Iowa: 2,296
-
Kansas: 2,384
-
Kentucky: 4,262
-
Louisiana: 7,287
-
Maine: 975
-
Maryland: 7,823
-
Massachusetts: 5,123
-
Michigan:12,293
-
Minnesota: 3,697
-
Mississippi:5,456
-
Missouri:6,467
-
Montana: 627
-
Nebraska:1,473
-
Nevada: 2,294
-
New Hampshire: 690
-
New Jersey: 10,580
-
New Mexico: 2,451
-
New York: 23,612
-
North Carolina: 12,895
-
North Dakota: 501
-
Ohio: 13,761
-
Oklahoma:3,793
-
Oregon: 2,703
-
Pennsylvania: 14,201
-
Puerto Rico:4,032
-
Rhode Island: 838
-
South Carolina: 7,199
-
South Dakota: 689
-
Tennessee: 7,482
-
Texas: 32,383
-
Utah: 1,303
-
Vermont: 380
-
Virginia: 9,332
-
Washington: 5,026
-
West Virginia: 1,794
-
Wisconsin: 4,899
-
Wyoming:248
The high incidence of Dialysis treatment in Florida is due to the numbers of aging population. Our Florida Seniors are at risk for sudden heart attack form the dialysis medication GranuFlo and Naturalyte.
Fresenius labs has used GranuFlo and Naturalyte in Dialysis Treatments. Fresnius knew of the dangers and still used the medication. As a result many of our seniors have suffered cardiac arrest and heart problems
Fresenius Claima To Be Patient-Centered Care for Chronic Kidney Disease
Fresenius Medical Care North America is a major provider of kidney dialysis services and renal care products. We provide products, dialysis care services, education and support for Chronic Kidney Disease (CKD), including treatment options for later stage CKD.
Our dialysis care services include hemodialysis, peritoneal dialysis, education tools and transplant support services, in-center, at home, or in a hospital, to fit our patients needs. We manufacture and distribute a variety of dialysis products and equipment, including dialysis machines, dialyzers and other dialysis-related supplies.
FDA Issues Class 1 Recall of GranuFlo
In late March of 2012, the FDA became aware of the apparent link between GranuFlo and cardiac arrest, according to the New York Times. In response to information about this threat to dialysis patients, which GranuFlo producer Fresenius had not made public, the FDA issued a Safety Communication warning about the dangers of alkali dosing errors for products like GranuFlo and NaturaLyte in hemodialysis patients.
In June, the FDA then issued a Class 1 recall of GranuFlo. This is the most serious class of recall, issued when the FDA deems there to be "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death." The FDA described the reason for the recall thus:
The manufacturer is cautioning clinicians to be aware of the concentration of acetate or sodium diacetate (acetic acid plus acetate) contained in Fresenius Naturalyte Liquid and Granuflo Dry Acid Concentrate. Inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis. This may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest. This product may cause serious adverse health consequences, including death.
GranuFlo Lawsuits Mounting Up. Protect Our Seniors, File Your GranuFlo Lawsuit Today
GranuFlo and NaturaLyte lawsuits are being filed in courts around the country, after hundreds of patients suffered cardiac arrest, sudden cardiac death. Pur seniors are in danger. Serious heart problems have been reported following the use of the drugs during dialysis treatments. While Fresenius Medical, the manufacturer of GranuFlo and NaturaLyte, learned of the risks associated with the dialysis drugs in 2011, a GranuFlo and NaturaLyte recall was not announced until months later. GranuFlo and NaturaLyte lawsuits are now being filed on behalf of our seniors who are victims of serious heart side effects within 48 hours of a dialysis treatment with GranuFlo and Naturalyte. Problems include: sudden cardiac death, cardiopulmonary arrest, heart attack and the development of heart problems.
File Your GranuFlo Lawsuit and Protect Your Loved Ones. Get Justice form Manufacturers who value profits over harm to people. If you, a loved one or someone you are a caregiver for has been injured by a dialysis medication call the GranuFlo Lawyer Helpline of Free Legal Shiels today.